Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
替莫唑胺和甲氧胺(TRC-102,一种碱基切除修复抑制剂)治疗晚期实体瘤患者的I期临床试验
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-020-00962-x
Eads, Jennifer R; Krishnamurthi, Smitha S; Saltzman, Joel; Bokar, Joseph A; Savvides, Panos; Meropol, Neal J; Gibbons, Joseph; Koon, Henry; Sharma, Neelesh; Rogers, Lisa; Pink, John J; Xu, Yan; Beumer, Jan H; Riendeau, John; Fu, Pingfu; Gerson, Stanton L; Dowlati, Afshin